| Identification | Back Directory | [Name]
1-Cyclopentene-1-carboxylic acid, 2-[[[5-ethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3,4-thiadiazol-2(3H)-ylidene]amino]carbonyl]- | [CAS]
167006-13-5 | [Synonyms]
WK1492
WK-1492
WK14922K
WK-14922K
KRH-594 free acid
1-Cyclopentene-1-carboxylic acid, 2-[[[5-ethyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3,4-thiadiazol-2(3H)-ylidene]amino]carbonyl]- | [Molecular Formula]
C25H23N7O3S | [MOL File]
167006-13-5.mol | [Molecular Weight]
501.56 |
| Hazard Information | Back Directory | [Description]
KRH-594, also known as WK-1492; WK-14922K, is a potent, specific and insurmountable AT1 receptor antagonist. KRH-594 prevents end-organ damage in stroke-prone spontaneously hypertensive/Izm rats. KRH-594 ameliorates nephropathy and hyperlipidaemia in diabetic spontaneously hypertensive rats. |
|
|